Vimarsana
Biggest News Aggregation in the World

Page 24 - Inducement Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inducement Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inducement Plan Today - Breaking & Trending Today

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - Vimarsana News

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)

WALTHAM - ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that on March 31, 2023, the Compensation Committee of the... | April 4, 2023

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that on March 31, 2023, the Compensation Committee of the Company’s... | April 3, 2023

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on March 31,... | March 31, 2023

Sonder Holdings Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Sonder Holdings Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

17.03.2023 - Sonder Holdings Inc. (NASDAQ: SOND; “Sonder”) today announced that on March 16, 2023, the Compensation Committee of Sonder’s Board of Directors made an equity inducement grant of stock options to Mr. Dominique Bourgault in connection with his ...

Aeglea BioTherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Aeglea BioTherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as...